DR. PETER HOTEZ
Dean, National School of Tropical Medicine, Baylor College of Medicine
Professor, Pediatrics & Molecular Virology and Microbiology, Baylor College of Medicine
Health Policy Scholar, Center for Medical Ethics and Health Policy, Baylor College of Medicine
Co-Director, Center for Vaccine Development, Texas Children's Hospital
Endowed Chair, Tropical Pediatrics, Texas Children's Hospital
Founding Editor in Chief, PLOS Neglected Tropical Diseases
Fellow in Disease and Poverty, James A. Baker III Institute for Public Policy, Rice University
Dr. Hotez is an internationally recognized physician-scientist in neglected tropical diseases and vaccine development, leading global efforts to development new vaccines for poverty-related neglected diseases affecting hundreds of millions of people. After obtaining his undergraduate degree in molecular biophysics from Yale University (Phi Beta Kappa) in 1980, Dr. Hotez received a Ph.D. in biochemistry from Rockefeller University in 1986 and an M.D. from Weil Cornell Medical College in 1987. He has authored more than 500 original scientific papers and is the author of four single-author books. He is an elected member of the National Academy of Medicine (Public Health Section) and the American Academy of Arts & Sciences (Public Policy Section). He served previously as President of the American Society of Tropical Medicine and Hygiene. In 2011, he received the Abraham Horwitz Award for Excellence in Leadership in Inter-American Health by the Pan American Health Organization of the World Health Organization.
Beyond his scientific accomplishments, in 2006, he established a Global Network for Neglected Tropical Diseases at the Clinton Global Initiative, now providing access to essential medicines for more than one billion people. In 2014-16, he served in the Obama Administration as US Envoy, focusing on vaccine diplomacy initiatives between the US government and countries in the Middle East and North Africa. In 2018, the US State Department appointed Dr. Hotez to serve on the Board of Governors for the US Israel Binational Science Foundation, and he is frequently called upon to testify before the US Congress. He has served on infectious disease task forces for two consecutive Texas Governors. For these efforts, he was named by FORTUNE Magazine as one of the 34 most influential people in health care in 2017. In 2018, he received the Sustained Leadership Award from Research! America, and in 2019, he received the Ronald McDonald House Charities Award for Medical Excellence. Most recently as both a vaccine scientist and autism parent, Dr. Hotez has led national efforts to defend vaccines and to serve as an ardent champion of vaccines, going up against a growing national “antivax” threat. In 2019, he received the Award for Leadership in Advocacy for Vaccines from the American Society of Tropical Medicine and Hygiene. Dr. Hotez appears frequently on television (including BBC, CNN, Fox News, and MSNBC), radio, and in newspaper interviews.
Featured Presentations
Consortium of Universities for Global Health Virtual Conference
Women Leaders in the COVID-19 Pandemic Response
March 2021
BIPAI Network Meeting
COVID-19 and Vaccine Development
November 2020
Consortium of Universities for Global Health Webinar
Vaccines & Vaccine Hesistancy
July 2019
Podcasts
Articles
Meet the Texas Doctor Developing a “People’s Vaccine” to Help Inoculate Billions Around the World
Op-Ed: Most of the world has no COVID-19 vaccine. That’s a huge global threat
These Researchers Have Developed an Inexpensive, Low-Tech COVID Vaccin
FEATURED PUBLICATIONS
Hotez PJ. America's deadly flirtation with antiscience and the medical freedom movement. J Clin Invest. 2021 Apr 01; 131(7). PMID: 33630759.
Hayon J, Weatherhead J, Hotez PJ, Bottazzi ME, Zhan B. Advances in vaccine development for human trichuriasis. Parasitology. 2021 Mar 24; 1-40. PMID: 33757603.
Hotez PJ, Nuzhath T, Callaghan T, Colwell B. COVID-19 Vaccine Decisions: Considering the Choices and Opportunities. Microbes Infect. 2021 Mar 17; 104811. PMID: 33744495.
Chen WH, Wei J, Kundu RT, Adhikari R, Liu Z, Lee J, Versteeg L, Poveda C, Keegan B, Villar MJ, de Araujo Leao AC, Rivera JA, Gillespie PM, Pollet J, Strych U, Zhan B, Hotez PJ, Bottazzi ME. Genetic modification to design a stable yeast-expressed recombinant SARS-CoV-2 receptor binding domain as a COVID-19 vaccine candidate. Biochim Biophys Acta Gen Subj. 2021 Mar 14; 1865(6):129893. PMID: 33731300.
Hotez P, Batista C, Ergonul O, Figueroa JP, Gilbert S, Gursel M, Hassanain M, Kang G, Kim JH, Lall B, Larson H, Naniche D, Sheahan T, Shoham S, Wilder-Smith A, Strub-Wourgaft N, Yadav P, Bottazzi ME. Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members. EClinicalMedicine. 2021 Mar; 33:100780. PMID: 33718854.
Talavera-López C, Messenger LA, Lewis MD, Yeo M, Reis-Cunha JL, Matos GM, Bartholomeu DC, Calzada JE, Saldaña A, Ramírez JD, Guhl F, Ocaña-Mayorga S, Costales JA, Gorchakov R, Jones K, Nolan MS, Teixeira SMR, Carrasco HJ, Bottazzi ME, Hotez PJ, Murray KO, Grijalva MJ, Burleigh B, Grisard EC, Miles MA, Andersson B. Repeat-Driven Generation of Antigenic Diversity in a Major Human Pathogen, Trypanosoma cruzi. Front Cell Infect Microbiol. 2021; 11:614665. PMID: 33747978.
Hotez P. COVID-19 and the rise of anti-science. Expert Rev Vaccines. 2021 Feb 22; 1-3. PMID: 33599568.
Ramírez JD, Sordillo EM, Gotuzzo E, Zavaleta C, Caplivski D, Navarro JC, Crainey JL, Luz SLB, Delgado Noguera LA, Schaub R, Rousseau C, Herrera G, Oliveira-Miranda MA, Quispe-Vargas MT, Hotez PJ, Paniz Mondolfi A. Correction: SARS-CoV-2 in the Amazon region: A harbinger of doom for Amerindians. PLoS Negl Trop Dis. 2021 Feb; 15(2):e0009118. PMID: 33561162.